Fatal pulmonary hypertension in primary Sjøogren's syndrome [6]

Clinical and Experimental Rheumatology

Volumn 22, Issue 4, 2004, Pages 507-

  Aslaksen, H K ^a   Nossent, Hans C ^a,b  

^a UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^b UNIVERSITY OF TROMSØ   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYCHLOROQUINE; LOW MOLECULAR WEIGHT HEPARIN; OXYGEN;

ADULT; AUTOPSY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; ECHOGRAPHY; FEMALE; HUMAN; LABORATORY TEST; LETTER; OUTCOMES RESEARCH; PATIENT REFERRAL; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SJOEGREN SYNDROME; SYMPTOMATOLOGY;

FATAL OUTCOME; FEMALE; HUMANS; HYPERTENSION, PULMONARY; LUNG; MIDDLE AGED; SJOGREN'S SYNDROME;

EID: 4143152855     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (10)

1. CAIN HC, NOBLE PW, MATTHAY RA: Pulmonary manifestations of Sjogren's syndrome. Clin Chest Med 1998; 19: 687-99.
2. MAGLIANO M, ISENBERG DA, HILLSON J: Pulmonary hypertension in autoimmune rheumatic diseases: where are we now? Arthritis Rheum 2002; 46: 1997-2009.
3. VITALI C, MOUTSOPOULOS HM, BOMBARDIERI S: The European Community Study Group on diagnostic criteria for Sjögren's syndrome. Sensitivity and specificity of tests for ocular and oral involvement in Sjogren's syndrome. Ann Rheum Dis 1994; 53: 637-47.
4. GALLERANI M, GOVONI M, RICCI L et al.: a 49-year-old woman with dyspnoea, palpitations and syncope. Int J Cardiol 1996; 55: 67-78.
5. DAVIDSON BK, KELLY CA, GRIFFITHS ID: Ten year follow up of pulmonary function in patients with primary Sjogren's syndrome. Ann Rheum Dis 2000; 59: 709-12.
6. RASHID A, LEHRMAN S, ROMANO P, FRISHMAN W, DOBKIN J, REICHEL J: Primary pulmonary hypertension. Heart Dis 2000; 2: 422-30.
7. McLAUGHLIN VV: Medical management of primary pulmonary hypertension. Expert Opin Pharmacother 2002; 3: 159-65.
8. MARIETTE X, BRENOT F, BROUET JC: Recovery from pulmonary hypertension with steroid therapy in a patient with Sjögren's syndrome and polymyositis. J Rheumatol 1994; 21: 772-3.
9. CHANNICK RN, RUBIN LJ: New and experimental therapies for pulmonary hypertension. Clin Chest Med 2001; 22: 539-45.
10. CHANNICK RN, SIMONNEAU G, SITBON O et al.: Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study. Lancet 2001; 358: 119-23.